IL27 and neoplasm: Identification of IL30 as an upstream regulator of oncogenes, tumor suppressor and immunity genes, substantiates the use of CRISPR/Cas9-based deletion of IL30 to demolish the downstream tumor-promoting machinery and provides a new tool for the cure or prevention of advanced disease.